HanchorBio today announced that its proprietary HCB101, a SIRPa/CD47 fusion protein candidate, has been officially granted a US patent (Patent No. 12,447,195) by the United States Patent and Trademark Office (USPTO). Titled “ENGINEERED SIRPa VARIANTS AND METHODS OF USE THEREOF”, the patent represents major international recognition for the company's innovative technology for immuno-oncology. Mechanism of […]
Enhancements to the industry-leading high-performance computing and cloud platform elevate next-generation computing Altair, a global leader in computational intelligence, today announced significant upgrades to theAltair® HPCWorks® high-performance computing (HPC) and cloud platform. The release of Altair HPCWorks 2026 enables faster discovery with new features and improvements including enhanced GPU integration and utilization, expanded AI and
The collaboration provides field technicians with immediate access to model-specific information, embedded within the software they already know and trust Housecall Pro®, a top software platform built to empower home service contractors, announces a strategic partnership and integration withBluon, Inc., the HVAC industry's leading provider of technical data and AI-powered support tools. This in-app integration
The collaboration equips Housecall Pro users with HVAC's most powerful support toolkit to augment their technicians and combat the skilled labor shortage Bluon, Inc., an innovative software company that provides indispensable technical data and support via its proprietary database and AI platform to boost productivity for HVAC contractors and their service technicians, today announced a
Joint contribution highlights the insurance industry's role in investing in the long-term well-being of Canadians The Western Communities Foundation, the charitable arm of Western Financial Group, in partnership with Wawanesa Insurance are proud to make a joint $100,000 donation to the Health Sciences Centre (HSC) Foundation's Operation Excellence Campaign. This impactful contribution supports surgical innovation
Hengrui Pharma and Kailera Therapeutics Announce Phase 3 HRS9531 Obesity Data Presentation at ObesityWeek(R) 2025 Results from Hengrui's completed Phase 3 clinical trial of HRS9531, a novel dual GLP-1/GIP receptor agonist with potentially best-in-category weight loss, to be presented in an oral session GlobeNewswire October 21, 2025 SHANGHAI and WALTHAM, Mass., Oct. 21, 2025 (GLOBE
Star Fashion Culture Holdings Limited Announces Receipt of Nasdaq Minimum Bid Price Notification GlobeNewswire October 21, 2025 XIAMEN, Oct. 21, 2025 (GLOBE NEWSWIRE) — STAR FASHION CULTURE HOLDINGS LIMITED (NASDAQ: STFS) (the “Company” or “STFS”) today announced that on October 6, 2025, STAR FASHION CULTURE HOLDINGS LIMITED (the “Company”) received a letter from the Listing
XCHG Limited Publishes 2024 Environmental, Social and Governance Report GlobeNewswire October 21, 2025 HAMBURG, Germany, Oct. 21, 2025 (GLOBE NEWSWIRE) — XCHG Limited (“XCharge” or the “Company”), (Nasdaq: XCH), a global leader in integrated EV charging solutions, today published its 2024 Environmental, Social and Governance Report (the “2024 ESG Report”). The Report highlights XCharge's achievements
Plug Proves European Hydrogen Supply and Delivery Capabilities; Successfully Completes Deliveries to H2CAST Project, Signs New Contract for Additional 35 Tons On-time, successful delivery demonstrates scalability of Plug's European hydrogen production capacity and trucking fleet to support Germany's energy transition GlobeNewswire October 21, 2025 SLINGERLANDS, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) — Plug Power Inc.
Nasdaq Reports Third Quarter 2025 Results; Surpassing $1 Billion in Solutions Quarterly Revenue and $3 Billion in ARR GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2025. Third quarter 2025 net revenue1 was $1.3 billion, an increase of